Lin Elizabeth Yeu

CIK 00018421902 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001842190

Recent Transactions

42 trades

Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-19$67.00/sh−390→ 23,308 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-18$68.71/sh−379→ 23,698 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-17$69.42/sh−375→ 24,077 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-15+2,511→ 24,452 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-15−2,511→ 7,534 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-03-05+27,310→ 27,310 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-05+17,161→ 17,161 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-16$79.50/sh−2,078→ 21,941 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-15+6,819→ 24,019 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-12-15−6,819→ 20,459 total
Award
STAAR SURGICAL CO$STAA
Restricted Stock Units
2025-06-18+5,341→ 5,341 total
Award
STAAR SURGICAL CO$STAA
Common Stock Options
2025-06-18+9,708→ 9,708 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-06-16$41.08/sh−1,006→ 7,694 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-06-13+3,350→ 8,700 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-06-13−3,350→ 0 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-05+10,045→ 10,045 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-03-05+15,314→ 15,314 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-11-04+41,074→ 41,074 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-11-04+27,278→ 27,278 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-06-24−3,350→ 0 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-06-24+3,350→ 5,350 total
Award
STAAR SURGICAL CO$STAA
Common Stock
2024-06-20+2,244→ 5,099 total
Award
STAAR SURGICAL CO$STAA
Common Stock Options
2024-06-20+4,010→ 4,010 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-06-13+5,000→ 5,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-06-13+3,350→ 3,350 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-01-25+10,000→ 10,000 total
Purchase
STAAR SURGICAL CO$STAA
Common Stock
2023-09-21$40.00/sh+2,500→ 2,855 total
Purchase
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-08-15$16.80/sh+9,506→ 15,866 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2023-06-22+5,000→ 5,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-06-22+3,350→ 3,350 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-16+2,000→ 2,000 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-06-16−2,000→ 0 total
Exercise/Conversion
STAAR SURGICAL CO$STAA
Common Stock Options
2023-06-15+6,256→ 6,256 total
Purchase
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-09-14$16.03/sh+12,040→ 12,040 total
Purchase
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-09-14$16.29/sh+6,360→ 6,360 total
Exercise/Conversion
STAAR SURGICAL CO$STAA
Common Stock
2022-06-16+355→ 355 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-06-16+2,000→ 2,000 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Employee Stock Option (right to buy)
2022-06-16+7,000→ 7,000 total
Exercise/Conversion
STAAR SURGICAL CO$STAA
Common Stock Options
2022-06-16+5,765→ 5,765 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-12-31+20,000→ 20,000 total
Award
STAAR SURGICAL CO$STAA
Common Stock Options
2021-06-24+1,703→ 1,703 total
Award
STAAR SURGICAL CO$STAA
Common Stock Options
2021-01-21+1,367→ 1,367 total

Companies

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160

IRVINE, CA, 92618

View on SEC.gov